<DOC>
	<DOCNO>NCT02130947</DOCNO>
	<brief_summary>This randomize pilot study conduct men metastatic castration resistant prostate cancer ( mCRPC ) within 3 month initiate abiraterone enzalutamide . The purpose pilot study evaluate effect 12 week exercise intervention mCRPC patient recently start additional androgen suppression therapy .</brief_summary>
	<brief_title>Exercise Intervention Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Enzalutamide</brief_title>
	<detailed_description>This randomize pilot study conduct men metastatic castration resistant prostate cancer ( mCRPC ) within 3 month initiate abiraterone enzalutamide . The purpose pilot study evaluate effect 12 week exercise intervention mCRPC patient recently start additional androgen suppression therapy . The investigator also explore effect exercise train biomarkers inflammation-hormonal status potential association change lean mass function .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>1 . â‰¥18 year age 2 . Metastatic disease progress despite castrate level testosterone ( surgically medically castrate , testosterone level &lt; 50 ng/dL ) 3 . No prior chemotherapy 4 . Initiated therapy either abiraterone plus glucocorticoid enzalutamide within 3 month prior randomization 5 . Ability engage safely moderate exercise determine treat physician 6 . Not previously engage regular exercise training ( &gt; 12 d/wk &gt; 30 min/d ) past 6 month 7 . Be able speak read English 1 . Any condition cause severe pain exertion 2 . History bone fracture 3 . Active cardiovascular disease include follow : New York Heart Association ( NYHA ) Grade II great congestive heart failure History myocardial infarction unstable angina within 6 month prior Day 1 History stroke transient ischemic attack within 6 month prior Day 1 4 . Acute chronic respiratory disease 5 . Acute chronic bone/joint/muscular abnormality compromise ability exercise 6 . Neurological condition affect balance , muscle strength 7 . Dementia , alter mental status psychiatric condition prohibit understanding rendering informed consent</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Metastatic Castration Resistant Prostate Cancer</keyword>
	<keyword>Prostate Cancer</keyword>
	<keyword>mCRPC</keyword>
	<keyword>Pilot Study</keyword>
	<keyword>UNC Lineberger</keyword>
	<keyword>Exercise</keyword>
</DOC>